127 related articles for article (PubMed ID: 37534725)
41. Maternal human leukocyte antigen A*2301 is associated with increased mother-to-child HIV-1 transmission.
Mackelprang RD; Carrington M; John-Stewart G; Lohman-Payne B; Richardson BA; Wamalwa D; Gao X; Majiwa M; Mbori-Ngacha D; Farquhar C
J Infect Dis; 2010 Oct; 202(8):1273-7. PubMed ID: 20812845
[TBL] [Abstract][Full Text] [Related]
42. HLA allele sharing and HIV type 1 viremia in seroconverting Zambians with known transmitting partners.
Tang J; Tang S; Lobashevsky E; Zulu I; Aldrovandi G; Allen S; Kaslow RA;
AIDS Res Hum Retroviruses; 2004 Jan; 20(1):19-25. PubMed ID: 15000695
[TBL] [Abstract][Full Text] [Related]
43. Comparison of viral load and human leukocyte antigen statistical and neural network predictive models for the rate of HIV-1 disease progression across two cohorts of homosexual men.
Ioannidis JP; Goedert JJ; McQueen PG; Enger C; Kaslow RA
J Acquir Immune Defic Syndr Hum Retrovirol; 1999 Feb; 20(2):129-36. PubMed ID: 10048899
[TBL] [Abstract][Full Text] [Related]
44. Phylogenetic dependency networks: inferring patterns of CTL escape and codon covariation in HIV-1 Gag.
Carlson JM; Brumme ZL; Rousseau CM; Brumme CJ; Matthews P; Kadie C; Mullins JI; Walker BD; Harrigan PR; Goulder PJ; Heckerman D
PLoS Comput Biol; 2008 Nov; 4(11):e1000225. PubMed ID: 19023406
[TBL] [Abstract][Full Text] [Related]
45. Soluble HLA-G inhibits myeloid dendritic cell function in HIV-1 infection by interacting with leukocyte immunoglobulin-like receptor B2.
Huang J; Burke P; Yang Y; Seiss K; Beamon J; Cung T; Toth I; Pereyra F; Lichterfeld M; Yu XG
J Virol; 2010 Oct; 84(20):10784-91. PubMed ID: 20702625
[TBL] [Abstract][Full Text] [Related]
46. Interactive selective pressures of HLA-restricted immune responses and antiretroviral drugs on HIV-1.
John M; Moore CB; James IR; Mallal SA
Antivir Ther; 2005; 10(4):551-5. PubMed ID: 16038481
[TBL] [Abstract][Full Text] [Related]
47. HLA-associated immune escape pathways in HIV-1 subtype B Gag, Pol and Nef proteins.
Brumme ZL; John M; Carlson JM; Brumme CJ; Chan D; Brockman MA; Swenson LC; Tao I; Szeto S; Rosato P; Sela J; Kadie CM; Frahm N; Brander C; Haas DW; Riddler SA; Haubrich R; Walker BD; Harrigan PR; Heckerman D; Mallal S
PLoS One; 2009 Aug; 4(8):e6687. PubMed ID: 19690614
[TBL] [Abstract][Full Text] [Related]
48. Unique features of HLA-mediated HIV evolution in a Mexican cohort: a comparative study.
Avila-Rios S; Ormsby CE; Carlson JM; Valenzuela-Ponce H; Blanco-Heredia J; Garrido-Rodriguez D; Garcia-Morales C; Heckerman D; Brumme ZL; Mallal S; John M; Espinosa E; Reyes-Teran G
Retrovirology; 2009 Aug; 6():72. PubMed ID: 19664284
[TBL] [Abstract][Full Text] [Related]
49. Identifying the immune interactions underlying HLA class I disease associations.
Debebe BJ; Boelen L; Lee JC; ; Thio CL; Astemborski J; Kirk G; Khakoo SI; Donfield SM; Goedert JJ; Asquith B
Elife; 2020 Apr; 9():. PubMed ID: 32238263
[TBL] [Abstract][Full Text] [Related]
50. Influence of host genes on HIV-1 disease progression.
Roger M
FASEB J; 1998 Jun; 12(9):625-32. PubMed ID: 9619442
[TBL] [Abstract][Full Text] [Related]
51. Adaptive evolution of HIV at HLA epitopes is associated with ethnicity in Canada.
Ragonnet-Cronin M; Aris-Brosou S; Joanisse I; Merks H; Vallee D; Caminiti K; Sandstrom P; Brooks J
PLoS One; 2012; 7(5):e36933. PubMed ID: 22693560
[TBL] [Abstract][Full Text] [Related]
52. Role of HLA class I (HLA-A, B) and HLA class II (HLA-DRB, DQB) in HIV-1 patients with and without pulmonary tuberculosis.
Shankarkumar U; Pawar A; Prabu G; Ghosh K
J Acquir Immune Defic Syndr; 2009 Aug; 51(5):640-1. PubMed ID: 19628981
[No Abstract] [Full Text] [Related]
53. HLA and other host factors in transfusion-acquired HIV-1 infection.
Geczy AF; Kuipers H; Coolen M; Ashton LJ; Kennedy C; Ng G; Dodd R; Wallace R; Le T; Raynes-Greenow CH; Dyer WB; Learmont JC; Sullivan JS
Hum Immunol; 2000 Feb; 61(2):172-6. PubMed ID: 10717811
[TBL] [Abstract][Full Text] [Related]
54. Novel HLA class I associations with HIV-1 control in a unique genetically admixed population.
Valenzuela-Ponce H; Alva-Hernández S; Garrido-Rodríguez D; Soto-Nava M; García-Téllez T; Escamilla-Gómez T; García-Morales C; Quiroz-Morales VS; Tapia-Trejo D; Del Arenal-Sánchez S; Prado-Galbarro FJ; Hernández-Juan R; Rodríguez-Aguirre E; Murakami-Ogasawara A; Mejía-Villatoro C; Escobar-Urias IY; Pinzón-Meza R; Pascale JM; Zaldivar Y; Porras-Cortés G; Quant-Durán C; Lorenzana I; Meza RI; Palou EY; Manzanero M; Cedillos RA; Aláez C; Brockman MA; Harrigan PR; Brumme CJ; Brumme ZL; Ávila-Ríos S; Reyes-Terán G;
Sci Rep; 2018 Apr; 8(1):6111. PubMed ID: 29666450
[TBL] [Abstract][Full Text] [Related]
55. HIV/AIDS. HLA leaves its footprints on HIV.
McMichael A; Klenerman P
Science; 2002 May; 296(5572):1410-1. PubMed ID: 12029119
[No Abstract] [Full Text] [Related]
56. Human leukocyte antigen class I genotypes in relation to heterosexual HIV type 1 transmission within discordant couples.
Tang J; Shao W; Yoo YJ; Brill I; Mulenga J; Allen S; Hunter E; Kaslow RA
J Immunol; 2008 Aug; 181(4):2626-35. PubMed ID: 18684953
[TBL] [Abstract][Full Text] [Related]
57. Associations of functional human leucocyte antigen class I groups with HIV viral load in a heterogeneous cohort.
Zucco AG; Bennedbæk M; Ekenberg C; Gabrielaite M; Leung P; Polizzotto MN; Kan V; Murray DD; Lundgren JD; MacPherson CR;
AIDS; 2023 Sep; 37(11):1643-1650. PubMed ID: 37534724
[TBL] [Abstract][Full Text] [Related]
58. Passive sexual transmission of human immunodeficiency virus type 1 variants and adaptation in new hosts.
Frater AJ; Edwards CT; McCarthy N; Fox J; Brown H; Milicic A; Mackie N; Pillay T; Drijfhout JW; Dustan S; Clarke JR; Holmes EC; Zhang HT; Pfafferott K; Goulder PJ; McClure MO; Weber J; Phillips RE; Fidler S
J Virol; 2006 Jul; 80(14):7226-34. PubMed ID: 16809328
[TBL] [Abstract][Full Text] [Related]
59. Persistence of high levels of blood soluble human leukocyte antigen-G is associated with rapid progression of HIV infection.
Lajoie J; Fontaine J; Tremblay C; Routy JP; Poudrier J; Roger M
AIDS; 2009 Jul; 23(11):1437-40. PubMed ID: 19461504
[TBL] [Abstract][Full Text] [Related]
60. HLA and HIV-1: heterozygote advantage and B*35-Cw*04 disadvantage.
Carrington M; Nelson GW; Martin MP; Kissner T; Vlahov D; Goedert JJ; Kaslow R; Buchbinder S; Hoots K; O'Brien SJ
Science; 1999 Mar; 283(5408):1748-52. PubMed ID: 10073943
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
